Optimizing the Journey of the Immuno-Oncology Patient: An Interprofessional Educational Initiative

During this half-day educational initiative, expert faculty will review biomarkers for immunotherapies across tumor types and managing adverse events.
0.00 available credits
During this half-day educational initiative, expert faculty will review biomarkers for immunotherapies across tumor types and managing adverse events.
0.00 available credits
Enroll in this meeting
May 10, 2019
09:00 AM - 01:00 PM GMT
The King's Fund
No. 11 Cavendish Square, W1G 0AN, London, United Kingdom
Enrollment Fee: Free
Free
  • Overview

    Oncology patient receiving immunotherapy often present to a variety of different medical specialists, GPs, and other healthcare professionals.  The care of the patients can involve ongoing treatment oversight, management of adverse events, and caring for co- and multi-morbid conditions.  In order to help educate the healthcare professionals who may encounter these patients, IC-ONC, a global community of learning was formed.

    You are invited to join this community of learners, and to attend this complimentary half-day educational initiative designed to help improve the interprofessional care of these patients. The content for this educational activity was developed by a group of global experts representing the specialties and professions involved in the care of these patients, and local expert faculty, Dr. Peter Schmid and Farah Lim, will use engaging and interactive techniques to address best practices in caring for these patient.

    Your participation in this unique educational initiative automatically registers you as a part of this global learning community and will allow you to access a variety of educational resources. There will be ongoing follow-up by and access to the expert faculty to help incorporate the learning into practice.. 

  • What is IC-ONC?

    The Immunotherapy Collaborative of Networked Communities (IC-ONC), is a partnership between a variety of stakeholders in interprofessional education: professional societies, educational providers, and outcomes partners. This initiative allows oncology clinicians from medicine, nursing, and pharmacy to form a community of learners, which will be part of a larger global educational community.  IC-ONC recognises the role interprofessional education can play in creating an environment of collaboration and learning amongst clinicians. 

  • Program Topics*

    • Optimizing Immuno-oncology Therapy Through the Management of Adverse Events
    • Tumor Mutational Burden and Microsatellite Instability
    • Biomarkers for Immunotherapies Across Tumor Types

    *Topics subject to change.

  • Target Audience

    This activity is designed to meet the needs of medical oncologists, surgical oncologists, radiation oncologists, oncology nurses, oncology pharmacists, general practitioners, emergency medicine physicians and emergency nurses. Others involved in the care of oncology patients who receive immunotherapy are also encouraged to participate.

  • Educational Partner

    Produced in collaboration with the Immunotherapy Collaborative of Oncology Networked Communities.

  • Commercial Support Statement

    This activity is supported by an educational grant from Bristol Myers-Squibb.

  • Accreditation and Credit Designation Statements

    An application has being submitted to The Federation of the Royal Colleges of Physicians for CPD credit consideration.

Facebook Comments

Sign up for the Global Oncology Academy newsletters.
Comprehensive Oncology Education.

Better education for a better you.

* Required
Optional

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free